- Report
- August 2025
- 150 Pages
Global
From €3394EUR$3,850USD£2,981GBP
- Drug Pipelines
- June 2025
- 200 Pages
Global
From €2459EUR$2,789USD£2,160GBP
- Report
- June 2025
- 200 Pages
Global
From €2459EUR$2,789USD£2,160GBP
- Drug Pipelines
- June 2025
- 200 Pages
Global
From €2459EUR$2,789USD£2,160GBP
- Drug Pipelines
- June 2025
- 200 Pages
Global
From €2459EUR$2,789USD£2,160GBP
- Drug Pipelines
- June 2025
- 200 Pages
Global
From €2459EUR$2,789USD£2,160GBP
- Report
- June 2025
- 400 Pages
Global
From €4363EUR$4,949USD£3,832GBP
- Report
- June 2025
- 400 Pages
Global
From €4363EUR$4,949USD£3,832GBP
- Report
- June 2025
- 141 Pages
Global
From €3482EUR$3,950USD£3,059GBP
- Report
- September 2025
- 150 Pages
Global
From €3923EUR$4,450USD£3,446GBP
- Report
- August 2025
- 277 Pages
Global
From €3923EUR$4,450USD£3,446GBP
- Report
- September 2025
- 72 Pages
Global
From €3500EUR$4,253USD£3,182GBP
- Report
- May 2025
- 87 Pages
Global
From €3500EUR$4,253USD£3,182GBP
- Report
- October 2025
- 160 Pages
Global
From €2960EUR$3,358USD£2,600GBP
€3482EUR$3,950USD£3,059GBP
- Report
- October 2025
- 160 Pages
Global
From €2960EUR$3,358USD£2,600GBP
€3482EUR$3,950USD£3,059GBP
- Report
- October 2025
- 160 Pages
Global
From €2960EUR$3,358USD£2,600GBP
€3482EUR$3,950USD£3,059GBP
- Report
- October 2025
- 160 Pages
Global
From €2960EUR$3,358USD£2,600GBP
€3482EUR$3,950USD£3,059GBP
- Report
- October 2025
- 160 Pages
Global
From €2960EUR$3,358USD£2,600GBP
€3482EUR$3,950USD£3,059GBP
- Report
- October 2025
- 160 Pages
Global
From €2960EUR$3,358USD£2,600GBP
€3482EUR$3,950USD£3,059GBP
- Report
- January 2025
- 120 Pages
Global
€4990EUR$6,063USD£4,536GBP

Programmed Cell Death Protein (PDP) is a type of protein that plays a role in the regulation of cell death in the body. It is a key component of the body's natural defense against cancer, as it helps to prevent the growth and spread of cancerous cells. In oncology drugs, PDP is used to target and destroy cancer cells, while leaving healthy cells unharmed. PDP is also used to reduce the side effects of chemotherapy and radiation therapy, as well as to reduce the risk of recurrence of cancer. PDP is also used to reduce the risk of metastasis, or the spread of cancer to other parts of the body.
PDP is a rapidly growing market, with many companies developing and marketing PDP-based drugs. Some of these companies include Merck, Bristol-Myers Squibb, AstraZeneca, Novartis, and Pfizer. Show Less Read more